Tango Therapeutics, Inc. (TNGX) Shareholders’ equity 2020–2025
Tango Therapeutics, Inc. (TNGX) shareholders’ equity at each fiscal year-end, per SEC filings.
$346.2MFY2025 · since FY2020: $38.6M → $346.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $346.2M | +73.5% |
| FY2024 | $199.5M | -21.2% |
| FY2023 | $253.1M | +1.5% |
| FY2022 | $249.5M | -27.6% |
| FY2021 | $344.7M | +793.1% |
| FY2020 | $38.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice